ArticleJournal of clinical medicine2022

A Prospective Randomized, Double-Blind, Multi-Center, Phase III Clinical Trial Evaluating the Efficacy and Safety of Olmesartan/Amlodipine plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia: A LEISURE Study.

Sang-Ho Jo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.